Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Special attention has been paid to Hepatitis E (HE) prophylaxis for pregnant women due to poor prognosis of HE in this population. We conducted a post-hoc analysis based on the randomized, double-blind, HE vaccine (Hecolin)-controlled phase 3 clinical trial of human papillomavirus (HPV) vaccine (Cec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Guohua, Zhuang, Chunlan, Hu, Xiaowen, Chen, Qi, Bi, Zhaofeng, Jia, Xinhua, Peng, Siying, Li, Yufei, Huang, Yue, Zhang, Qiufen, Hong, Ying, Qiao, Youlin, Su, Yingying, Pan, Huirong, Wu, Ting, Wei, Lihui, Huang, Shoujie, Zhang, Jun, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026809/
https://www.ncbi.nlm.nih.gov/pubmed/36877135
http://dx.doi.org/10.1080/22221751.2023.2185456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026809/
https://www.ncbi.nlm.nih.gov/pubmed/36877135
http://dx.doi.org/10.1080/22221751.2023.2185456

Ejemplares similares